1. Brazil Stocks

  2. •

    Retail trade

  3. •

    Drugstore chains
Raia Drogasil S.A.

Raia Drogasil S.A.

20.32
BRL
-0.80
(-3.79%)
29.39BMarket Cap
Nov 03Next Earn
Raia Drogasil S.A.
B3:RADL3
(B3)

Recent

price

20.32

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
BRL
2.1
2.92
3.07
3.56
4.21
5.09
6.44
7.56
8.47
10.05
11.47
13.79
16.63
19.65
23.11
26.87
- -
Revenue per Share
0.09
0.07
0.06
0.06
0.13
0.19
0.26
0.29
0.29
0.44
0.28
0.43
0.57
0.61
0.71
0.79
- -
Basic EPS, GAAP
-0.05
-0.06
-0.09
0.04
0.04
0.07
0.04
-0.01
-0.01
0.26
0.46
0.4
-0.2
-0.2
0.37
0.06
- -
Free Cash Flow per Basic Share
0.03
0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.6
2.35
1.29
1.33
1.41
1.51
1.66
1.84
2
2.3
2.49
2.68
3.06
3.41
3.68
4.11
4.17
Book Value per Share
0.54
1.15
0.62
0.67
0.76
0.84
0.99
1.16
1.32
1.59
1.77
1.83
2.06
2.31
2.52
2.96
3
Tangible Book Value per Share
953
935
1,752
1,752
1,747
1,747
1,749
1,749
1,747
1,747
1,749
1,750
1,748
1,729
1,682
1,647
1,681
Basic Weighted Avg Shares
2,005
2,729
5,381
6,233
7,351
8,898
11,257
13,213
14,801
17,566
20,067
24,127
29,067
33,974
38,872
44,250
- -
Sales/Revenue/Turnover
5.6
2.92
2.99
2.4
4.66
5.63
6.27
6
5.18
5.07
4.46
5.69
6.42
5.75
6.1
5.99
- -
Operating Margin (%)
31
56
124
159
188
228
274
338
414
1,041
1,177
1,327
700
798
912
1,049
- -
Depreciation Expense
89
69
105
101
221
340
448
511
502
772
484
752
996
1,055
1,200
1,297
- -
Net Income, GAAP
26.33
24.68
33.67
27.55
26.75
22.05
24.19
25.33
20.28
- -
19.6
22.6
14.94
10.65
14.63
10.21
- -
Effective Tax Rate (%)
4.44
2.52
1.95
1.62
3.01
3.82
3.98
3.87
3.39
4.4
2.41
3.12
3.43
3.11
3.09
2.93
- -
Profit Margin (%)
379
835
831
884
969
1,037
1,243
1,434
1,616
1,678
2,219
1,823
3,210
3,482
3,509
4,711
4,116
Working Capital
28
112
131
161
184
188
281
415
570
3,516
4,050
3,865
5,112
5,604
6,130
7,305
7,202
LT Debt
599
2,201
2,265
2,327
2,457
2,657
2,936
3,250
3,535
4,076
4,426
4,719
5,403
6,028
6,447
7,336
7,291
Total Equity
10.92
3.68
4.33
4.22
1.58
13.51
16.6
15.93
13.6
- -
8.2
10.76
14.43
14.83
14.39
15.88
- -
Return on Invested Capital (%)
12.54
4.78
4.81
4.56
9.02
12.91
15.48
15.54
13.16
- -
7.84
10.14
13.61
13.7
13.81
14.84
- -
Return on Capital (%)
17.62
4.91
4.7
4.4
9.26
13.37
16.15
16.67
14.95
20.53
11.55
16.63
19.89
18.68
19.37
18.86
- -
Return on Common Equity (%)

Capital Structure

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,529
1,443
1,391
LT Borrowings
3,360
3,236
3,087
LT Finance Leases
3,945
4,015
4,115
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,782
1,749
1,749
Market Capitalization
41,793
41,143
29,393

Working Capital

BRL

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
14,904
15,357
14,252
Cash, Cash Equivalents & STI
529
538
653
Accounts Receivable, Net
3,401
2,835
3,096
Inventories
9,576
8,440
8,334
Total Current Liabilities
10,194
10,456
10,136
Payables & Accruals
- -
- -
- -
ST Debt
1,529
1,443
1,391
Deferred Revenue
- -
- -
- -

Growth Rates

BRL

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.73%
10.68%
13.79%
Free Cash Flow
-294.33%
-106.26%
-83.07%
Net Income, GAAP
17.59%
23.08%
8.08%
Sales/Revenue/Turnover
17.47%
17.17%
13.84%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9,100
9,687
9,989
10,088
38,872
2025
9,273
10,075
- -
12,103
44,250
2026
10,569
11,062
- -
- -
- -

Quarterly Earnings Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.19
0.2
0.2
0.71
2025
0.1
0.22
- -
0.17
0.79
2026
0.1
0.26
- -
- -
- -

Quarterly Dividends Per Share

BRL

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
CVS Health Corporation (NYSE:CVS)
MatsukiyoCocokara & Co. (TSE:3088)
Guardian Pharmacy Services, Inc. (NYSE:GRDN)
TSURUHA Holdings, Inc. (TSE:3391)
MedPlus Health Services Ltd. (NSE:MEDPLUS)
Sundrug Co., Ltd. (TSE:9989)
Business
Raia Drogasil SA (RADL3.SA) operates as Brazil's largest drugstore chain, retailing a broad range of pharmaceutical products, health and beauty items, personal care goods, household essentials, and over-the-counter medications through its Raia and Drogasil banners. The company offers prescription drugs, generic medicines, cosmetics from leading brands, baby products, hygiene supplies, and convenience items such as snacks and beverages; it also provides pharmacy services including vaccinations, blood pressure checks, and medication delivery via its RD app and website. Headquartered in Sao Paulo, Brazil, and founded in 2011 through the merger of Raia SA and Drogasil SA, Raia Drogasil conducts operations exclusively within Brazil, with over 2,800 stores across all regions of the country as of late 2024. In recent developments, the company expanded its store network by opening more than 200 new locations in 2024, strengthening its market leadership in the competitive retail pharmacy sector; it also enhanced its digital ecosystem with upgraded e-commerce capabilities and same-day delivery partnerships in major urban centers. Additionally, Raia Drogasil announced a strategic alliance with select health tech firms in early 2025 to integrate telehealth consultations within its stores, alongside a major funding initiative via a secondary share offering to support accelerated growth amid rising consumer demand for integrated health services. The firm targets middle- and upper-income consumers, families, and chronic disease patients, operating within the retail pharmacy and health & wellness segments without notable subsidiaries or parent entities.

Company News

Company News APIChatGPT

  • defenseworld.net

    Village Super Market (NASDAQ:VLGEA) vs. Raia Drogasil (OTCMKTS:RADLY) Head to Head Contrast

  • defenseworld.net

    Raia Drogasil (OTCMKTS:RADLY) Shares Gap Down – Here’s What Happened

  • defenseworld.net

    Costco Wholesale (NASDAQ:COST) and Raia Drogasil (OTCMKTS:RADLY) Head-To-Head Contrast

  • defenseworld.net

    BJ’s Wholesale Club (NYSE:BJ) & Raia Drogasil (OTCMKTS:RADLY) Head to Head Comparison

  • defenseworld.net

    Head to Head Survey: Ingles Markets (NASDAQ:IMKTA) versus Raia Drogasil (OTCMKTS:RADLY)

  • seekingalpha.com

    Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript

  • defenseworld.net

    Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8%

  • seekingalpha.com

    Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call Transcript

  • defenseworld.net

    Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update

  • seekingalpha.com

    Raia Drogasil S.A. (RADLY) Q3 2025 Earnings Call Transcript

  • seekingalpha.com

    Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors

  • seekingalpha.com

    Raia Drogasil: Valuation Burn Now, Healthy Gains Later

  • investorplace.com

    What's Hot, What's Not: China Stocks Are Out. Top Picks From 3 Other Countries

  • investorplace.com

    3 Stocks to Ride the Latin America Market Boom in 2024

  • investorplace.com

    The 3 Best South American Stocks to Buy in 2023